Articles published by 89bio, Inc.
    89bio, Inc. Announces Agreement to be Acquired by Roche
    
   September 18, 2025
   From 89bio, Inc.
   Via GlobeNewswire
    Tickers
      ETNB
    
   
    89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    
   September 05, 2025
   From 89bio, Inc.
   Via GlobeNewswire
    Tickers
      ETNB
    
   
    89bio to Participate in Upcoming Investor Conferences
    
   August 28, 2025
   From 89bio, Inc.
   Via GlobeNewswire
    Tickers
      ETNB
    
   From 89bio, Inc.
   Via GlobeNewswire
    Tickers
      ETNB
    
   From 89bio, Inc.
   Via GlobeNewswire
    Tickers
      ETNB
    
   From 89bio, Inc.
   Via GlobeNewswire
    Tickers
      ETNB
    
   From 89bio, Inc.
   Via GlobeNewswire
    Tickers
      ETNB
    
    
   From 89bio, Inc.
   Via GlobeNewswire
    Tickers
      ETNB
    
   From 89bio, Inc.
   Via GlobeNewswire
    Tickers
      ETNB
    
   From 89bio, Inc.
   Via GlobeNewswire
    Tickers
      ETNB
    
   From 89bio, Inc.
   Via GlobeNewswire
    Tickers
      ETNB
    
    
   From 89bio, Inc.
   Via GlobeNewswire
    Tickers
      ETNB
    
    
   
    89bio Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates
    
   February 27, 2025
   From 89bio, Inc.
   Via GlobeNewswire
    Tickers
      ETNB
    
    
   
    89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    
   February 06, 2025
   From 89bio, Inc.
   Via GlobeNewswire
    Tickers
      ETNB
    
    
   
    89bio Announces Closing of its Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
    
   February 03, 2025
   From 89bio, Inc.
   Via GlobeNewswire
    Tickers
      ETNB
    
    
   
    89bio, Inc. Announces Pricing of $250.0 Million Public Offering of Common Stock and Pre-Funded Warrants
    
   January 28, 2025
   From 89bio, Inc.
   Via GlobeNewswire
    Tickers
      ETNB
    
    
   
    89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
    
   January 27, 2025
   From 89bio, Inc.
   Via GlobeNewswire
    Tickers
      ETNB
    
    
   
    89bio Provides Business Update and Outlook for 2025
    
   January 13, 2025
   From 89bio, Inc.
   Via GlobeNewswire
    Tickers
      ETNB
    
    
   
    89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    
   December 19, 2024
   From 89bio, Inc.
   Via GlobeNewswire
    Tickers
      ETNB
    
    
   
    89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    
   November 29, 2024
   From 89bio, Inc.
   Via GlobeNewswire
    Tickers
      ETNB
    
    
   
    89bio to Participate in the 7th Annual Evercore HealthCONx Conference
    
   November 26, 2024
   From 89bio, Inc.
   Via GlobeNewswire
    Tickers
      ETNB
    
    
    
   
    89bio, Inc. Announces Upsized Pricing of $125.0 Million Public Offering of Common Stock and Pre-Funded Warrants
    
   November 12, 2024
   From 89bio, Inc.
   Via GlobeNewswire
    Tickers
      ETNB
    
    
   
    89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
    
   November 12, 2024
   From 89bio, Inc.
   Via GlobeNewswire
    Tickers
      ETNB
    
    
   
    89bio Reports Third Quarter 2024 Financial Results and Corporate Updates
    
   November 07, 2024
   From 89bio, Inc.
   Via GlobeNewswire
    Tickers
      ETNB
    
    
   
    89bio to Participate in the UBS Global Healthcare Conference
    
   November 05, 2024
   From 89bio, Inc.
   Via GlobeNewswire
    Tickers
      ETNB
    
    
    
   From 89bio, Inc.
   Via GlobeNewswire
    Tickers
      ETNB
    
    
   From 89bio, Inc.
   Via GlobeNewswire
    Tickers
      ETNB
    
    
   
    89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    
   September 19, 2024
   From 89bio, Inc.
   Via GlobeNewswire
    Tickers
      ETNB
    
   
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
